HUMAHumacyteHUMA info
$4.64info34.10%24h
Global rank11897
Market cap$480.59M
Change 7d13.17%
YTD Performance59.45%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Humacyte (HUMA) Stock Overview

    Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

    HUMA Stock Information

    Symbol
    HUMA
    Address
    2525 East North Carolina Highway 54Durham, NC 27713United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.humacyte.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    919 313 9633

    Humacyte (HUMA) Price Chart

    -
    Value:-

    Humacyte Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $4.64
    N/A
    Market Cap
    $480.59M
    N/A
    Shares Outstanding
    103.58M
    N/A
    Employees
    164.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org